Login / Signup
Xiongbing Zu
ORCID
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 2
Top Topics
Squamous Cell
Poor Prognosis
Gene Expression
Top Venues
Cancer research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Xinyi Zhou
,
Yohei Sekino
,
Hong-Tao Li
,
Guanghou Fu
,
Zhi Yang
,
Shuqing Zhao
,
Hemant Gujar
,
Xiongbing Zu
,
Daniel J Weisenberger
,
Inderbir S Gill
,
Varsha Tulpule
,
Anishka D'souza
,
David I Quinn
,
Bo Han
,
Gangning Liang
SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer.
Cancer research
(2023)
Xufeng Lu
,
Dazhuan E Xin
,
Juanjuan K Du
,
Quanli C Zou
,
Qian Wu
,
Yanan S Zhang
,
Wenhai Deng
,
Jicheng Yue
,
Xing S Fan
,
Yuanyuan Zeng
,
Xiaju Cheng
,
Xue S Li
,
Zhaoyuan Hou
,
Man Mohan
,
Ting C Zhao
,
Xiaomei Lu
,
Zhijie Chang
,
Li-Yan Xu
,
Yu Sun
,
Xiongbing Zu
,
Yu Zhang
,
Y Eugene Chinn
Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression.
Cancer research
82 (23) (2022)